One Wealth Advisors LLC Has $1.11 Million Stake in McKesson Co. (NYSE:MCK)

One Wealth Advisors LLC decreased its stake in shares of McKesson Co. (NYSE:MCK) by 1.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 2,246 shares of the company’s stock after selling 25 shares during the period. One Wealth Advisors LLC’s holdings in McKesson were worth $1,112,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Distillate Capital Partners LLC increased its position in shares of McKesson by 127,542.9% during the 2nd quarter. Distillate Capital Partners LLC now owns 35,740 shares of the company’s stock valued at $20,874,000 after purchasing an additional 35,712 shares during the last quarter. Chase Investment Counsel Corp lifted its position in McKesson by 50.8% in the second quarter. Chase Investment Counsel Corp now owns 8,985 shares of the company’s stock valued at $5,247,000 after purchasing an additional 3,027 shares during the last quarter. Wealthspire Advisors LLC increased its stake in shares of McKesson by 8.9% during the second quarter. Wealthspire Advisors LLC now owns 1,623 shares of the company’s stock valued at $948,000 after buying an additional 133 shares during the period. Councilmark Asset Management LLC purchased a new stake in McKesson in the first quarter worth $5,160,000. Finally, Vaughan David Investments LLC IL purchased a new stake in McKesson in the second quarter worth $238,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Price Performance

Shares of NYSE:MCK traded up $0.71 during trading on Thursday, hitting $511.64. The company had a trading volume of 59,852 shares, compared to its average volume of 803,982. The stock has a market cap of $66.48 billion, a price-to-earnings ratio of 22.83, a price-to-earnings-growth ratio of 1.17 and a beta of 0.44. McKesson Co. has a one year low of $431.35 and a one year high of $637.51. The company has a fifty day simple moving average of $522.51 and a two-hundred day simple moving average of $552.42.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.21 by $0.67. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The firm had revenue of $79.28 billion during the quarter, compared to analyst estimates of $82.53 billion. During the same period last year, the company earned $7.27 EPS. McKesson’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, equities research analysts anticipate that McKesson Co. will post 32.07 earnings per share for the current year.

McKesson Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were given a dividend of $0.71 per share. The ex-dividend date was Friday, August 30th. This is a positive change from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 dividend on an annualized basis and a yield of 0.56%. McKesson’s payout ratio is 12.69%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on MCK shares. StockNews.com downgraded McKesson from a “buy” rating to a “hold” rating in a report on Friday, September 27th. Deutsche Bank Aktiengesellschaft lowered their price target on McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a report on Wednesday, September 25th. Argus upped their price target on McKesson from $570.00 to $670.00 and gave the company a “buy” rating in a report on Monday, June 24th. Wells Fargo & Company lowered their price target on McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a report on Friday, September 13th. Finally, Leerink Partners lowered their target price on McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a report on Monday, October 7th. Five analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and a consensus target price of $610.86.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Monday, August 5th. The stock was sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the completion of the sale, the chief executive officer now directly owns 82,339 shares of the company’s stock, valued at $51,546,684.17. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.11% of the stock is currently owned by corporate insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.